0.34%
4.78%
-5.09%
4.66%
-9.35%
-22.34%
-39.04%
AI Spotlight on FIE
Company Description
Fielmann Aktiengesellschaft, together with its subsidiaries, engages in the investment in and operation of optical and hearing aid businesses.The company manufactures and sells visual aids and other optical products, including glasses, frames, lenses, sunglasses, contact lenses and accessories, and various merchandise, as well as hearing aids and accessories.As of December 31, 2021, it operated 693 stores, including 610 in Germany, 45 in Switzerland, 38 Austria, 3 in Luxembourg, 43 in Italy, 37 in Poland, 87 in Spain, 32 in Slovenia, and 15 in the rest of Europe.
The company also 78 smaller locations in Eastern Europe.It also offers its products through online stores.The company was founded in 1972 and is headquartered in Hamburg, Germany.
Fielmann Aktiengesellschaft is a subsidiary of Korva SE.
Market Data
| Last Price | 43.8 |
| Change Percentage | 0.34% |
| Open | 43.85 |
| Previous Close | 43.65 |
| Market Cap ( Millions) | 3678 |
| Volume | 36545 |
| Year High | 48.35 |
| Year Low | 38.75 |
| M A 50 | 40.7 |
| M A 200 | 43.07 |
Financial Ratios
| FCF Yield | 3.15% |
| Dividend Yield | 2.28% |
| ROE | 14.93% |
| Debt / Equity | 52.76% |
| Net Debt / EBIDTA | 46.19% |
| Price To Book | 3.72 |
| Price Earnings Ratio | 26.45 |
| Price To FCF | 31.75 |
| Price To sales | 1.7 |
| EV / EBITDA | 9.85 |
News
- Nov -02 - Fielmann Group Third Quarter 2024 Earnings: Misses Expectations
- Oct -30 - The past five years for Fielmann Group (ETR:FIE) investors has not been profitable
- Oct -09 - Fielmann Group AG (ETR:FIE) On An Uptrend: Could Fundamentals Be Driving The Stock?
- Sep -17 - Are Investors Undervaluing Fielmann Group AG (ETR:FIE) By 48%?
- Sep -04 - Billionaire Hermès dynasty is so rich it can afford to make distant Gen Z relatives millionaires overnight
- Sep -01 - Analysts Are Updating Their Fielmann Group AG (ETR:FIE) Estimates After Its Half-Yearly Results
- Aug -31 - Fielmann Group Second Quarter 2024 Earnings: EPS: €0.52 (vs €0.39 in 2Q 2023)
- Aug -07 - Fielmann Group AG's (ETR:FIE) last week's 4.2% decline must have disappointed private companies who have a significant stake
- Jul -07 - Fielmann Group AG (ETR:FIE) Goes Ex-Dividend Soon
- Jun -15 - Fielmann Group's (ETR:FIE) Shareholders Will Receive A Bigger Dividend Than Last Year
- May -03 - Fielmann Group (ETR:FIE) Is Increasing Its Dividend To €1.00
- May -02 - Are Fielmann Group AG's (ETR:FIE) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
- Apr -10 - Are Investors Undervaluing Fielmann Group AG (ETR:FIE) By 34%?
- Mar -19 - Investors in Kingfisher (LON:KGF) have unfortunately lost 20% over the last three years
- Feb -29 - Under The Bonnet, BELIMO Holding's (VTX:BEAN) Returns Look Impressive
- Feb -29 - Insiders own 21% of Fielmann Group AG (ETR:FIE) shares but private companies control 55% of the company
- Nov -24 - Is Fielmann Group AG's (ETR:FIE) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
- Oct -27 - Kuehne + Nagel International (VTX:KNIN) Is Aiming To Keep Up Its Impressive Returns
- Oct -26 - A Look At The Fair Value Of Fielmann Group AG (ETR:FIE)
- Oct -10 - Here's What's Concerning About All for One Group's (ETR:A1OS) Returns On Capital
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Eyewear
Expected Growth : 7 %
What the company do ?
Fielmann Aktiengesellschaft's Eyewear segment offers a wide range of glasses, contact lenses, and other vision care products through its retail stores and online platforms.
Why we expect these perspectives ?
Fielmann's 7% growth in eyewear is driven by increasing demand for prescription glasses and contact lenses, particularly among aging populations. Expansion into Eastern Europe and online channels also contribute to growth. Additionally, the company's focus on innovative products, such as blue light blocking glasses, and its strong brand reputation support sales growth.
Segment n°2 -> Contact Lenses
Expected Growth : 6 %
What the company do ?
Contact Lenses from Fielmann Aktiengesellschaft are high-quality, corrective lenses designed for comfortable and clear vision, available in various materials and prescriptions.
Why we expect these perspectives ?
Fielmann's 6% growth in contact lenses is driven by increasing demand for daily disposables, expansion into emerging markets, and a growing online presence. Additionally, the company's focus on innovative products, such as silicone hydrogel lenses, and strategic partnerships with eye care professionals contribute to its growth momentum.
Segment n°3 -> Hearing Aids
Expected Growth : 5 %
What the company do ?
Fielmann Aktiengesellschaft's hearing aids offer customized solutions for individuals with hearing loss, providing discreet and innovative devices for improved communication.
Why we expect these perspectives ?
Fielmann's 5% growth in hearing aids is driven by an aging population, increasing awareness of hearing loss, and advancements in technology leading to more discreet and efficient devices. Additionally, government initiatives to improve access to hearing care and rising demand for personalized audio solutions contribute to the segment's growth.
Segment n°4 -> Sunglasses
Expected Growth : 8 %
What the company do ?
Fielmann Aktiengesellschaft's sunglasses offer stylish, high-quality eyewear with advanced lens technology and trendy designs for men and women.
Why we expect these perspectives ?
Fielmann's 8% growth in sunglasses is driven by increasing demand for premium and trendy eyewear, expansion into new markets, and strategic partnerships with fashion brands. Additionally, the company's strong online presence, competitive pricing, and wide product range contribute to its growth. Furthermore, the rising popularity of outdoor activities and growing awareness of eye health also boost sales.
Segment n°5 -> Other
Expected Growth : 4 %
What the company do ?
Fielmann Aktiengesellschaft's 'Other' segment includes revenue from licensing fees, wholesale of glasses, and other miscellaneous income.
Why we expect these perspectives ?
Fielmann's 'Other' segment growth is driven by increasing demand for online eye care services, expansion of its digital platform, and strategic partnerships. Additionally, the company's focus on sustainability and eco-friendly products resonates with environmentally conscious consumers, contributing to its growth.
Segment n°6 -> Services
Expected Growth : 9 %
What the company do ?
Fielmann Aktiengesellschaft offers services including eye exams, glasses, contact lenses, and hearing aids, as well as insurance and online shopping for optical products.
Why we expect these perspectives ?
Fielmann's 9% growth in services is driven by increasing demand for eye care and hearing aid services, expansion into new markets, strategic partnerships, and investments in digitalization and process optimization. Additionally, the company's focus on customer loyalty programs and employee training contributes to revenue growth.
Fielmann Aktiengesellschaft Products
| Product Range | What is it ? |
|---|---|
| Eyeglasses | Fielmann offers a wide range of eyeglasses for men, women, and children, including designer brands and in-house labels. |
| Contact Lenses | Fielmann supplies a variety of contact lenses, including daily disposables, monthly lenses, and colored lenses. |
| Sunglasses | Fielmann's sunglasses collection includes trendy and functional designs from popular brands and in-house labels. |
| Hearing Aids | Fielmann offers a range of hearing aids from leading manufacturers, including digital and analog models. |
| Eye Care Services | Fielmann's eye care services include eye exams, contact lens fittings, and vision therapy. |
Fielmann Aktiengesellschaft's Porter Forces
Threat Of Substitutes
Fielmann Aktiengesellschaft faces moderate threat from substitutes, as customers have limited alternatives for eye care services and products.
Bargaining Power Of Customers
Fielmann Aktiengesellschaft has a large customer base, which reduces the bargaining power of individual customers.
Bargaining Power Of Suppliers
Fielmann Aktiengesellschaft has a moderate dependence on suppliers for raw materials and equipment, which gives suppliers some bargaining power.
Threat Of New Entrants
Fielmann Aktiengesellschaft operates in a regulated industry with high barriers to entry, making it difficult for new entrants to join the market.
Intensity Of Rivalry
Fielmann Aktiengesellschaft operates in a highly competitive market with many established players, leading to intense rivalry among competitors.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 21.08% |
| Debt Cost | 3.95% |
| Equity Weight | 78.92% |
| Equity Cost | 6.71% |
| WACC | 6.13% |
| Leverage | 26.71% |
Fielmann Aktiengesellschaft : Quality Control
Fielmann Aktiengesellschaft passed 4 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| TECN.SW | Tecan Group AG provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. It operates through Life Sciences Business and Partnering Business … |
| YPSN.SW | Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates in two segments, Ypsomed Delivery Systems and … |
| AMP.MI | Amplifon S.p.A. retails hearing care products and services that help people rediscover various emotions of sound. The company offers ampli-easy, ampli-mini, ampli-connect, and ampli-energy hearing devices. It also provides fitting … |
| EKTA-B.ST | Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac … |
| CTEC.L | ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
Fielmann
A-Score
1-Year Total Return ->
🥈
Elekta
A-Score
1-Year Total Return ->
🥉
Ypsomed
A-Score
1-Year Total Return ->
4
ConvaTec
A-Score
1-Year Total Return ->
5
Amplifon
A-Score
1-Year Total Return ->
6
